ID
16370
Description
A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00337649
Link
https://clinicaltrials.gov/show/NCT00337649
Keywords
Versions (1)
- 7/13/16 7/13/16 -
Uploaded on
July 13, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00337649
Eligibility Breast Cancer NCT00337649
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Neuropathy Pre-existing
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0442874
- UMLS CUI [1,2]
- C2347662
Description
CNS metastases
Data type
boolean
Alias
- UMLS CUI [1]
- C0686377
Description
Congestive heart failure | Myocardial Infarction
Data type
boolean
Alias
- UMLS CUI [1]
- C0018802
- UMLS CUI [2]
- C0027051
Description
Malignant Neoplasms | Basal cell carcinoma Cured | Carcinoma in situ of uterine cervix Cured
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
- UMLS CUI [2,1]
- C0007117
- UMLS CUI [2,2]
- C1880198
- UMLS CUI [3,1]
- C0851140
- UMLS CUI [3,2]
- C1880198
Similar models
Eligibility Breast Cancer NCT00337649
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C0278488 (UMLS CUI [2])
C3495875 (UMLS CUI [2])
C0021044 (UMLS CUI [3,1])
C0449820 (UMLS CUI [3,2])
C1265611 (UMLS CUI [1,2])
C2939420 (UMLS CUI [2])
C2347662 (UMLS CUI [1,2])
C0027051 (UMLS CUI [2])
C0007117 (UMLS CUI [2,1])
C1880198 (UMLS CUI [2,2])
C0851140 (UMLS CUI [3,1])
C1880198 (UMLS CUI [3,2])